Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Amvis Holdings, Inc. (7071.T)
JPY386.00
+14.00 (+3.76%)
JP JPX Healthcare Medical - Care Facilities
Address
Mitsui Sumitomo Insurance TEPCO Building 104-0031
Tokyo, JP
Tokyo, JP
CEO
Keiichi Shibahara
Website
amvis.com
IPO
2019-10-09
ISIN JP3128660002
Description
Amvis Holdings, Inc. is a Japanese firm that delivers a wide array of care services. These offerings encompass residential nursing facilities, at-home nursing and general care, as well as various support programs for individuals with disabilities. Furthermore, the company provides consulting and other complementary services. Founded in 2013, Amvis Holdings maintains its headquarters in Tokyo, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY386.00
+14.00 (+3.76%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
468.6K
Beta
0.72
Float Shares
36.88M
Free Float %
37.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +6.09% | -4.94% | -12.23% | -27.09% | -19.56% | -20.61% | -17.94% | -87.94% | -78.05% | -29.78% | -29.78% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
386.00
Ratings Trend (MoM)
0% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 2 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.77
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+15.8% ★ Q1'26: +5.1% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-50.5% Q1'26: -39.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+9.7% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+12.5% ★ Q1'26: +9.5% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+6.1% Q1'26: +4.7% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.6% ★ Q1'26: +0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×4.49× Q1'26: 4.76× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 5 Rev. Ana. 5 EPS Ana. |
Sep 2027 5 Rev. Ana. 5 EPS Ana. |
Sep 2028 5 Rev. Ana. 5 EPS Ana. |
Sep 2029 2 Rev. Ana. 1 EPS Ana. |
Sep 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.37B
est: 5.24B (+2.5%)
|
9.17B
est: 8.88B (+3.4%)
|
15.33B
est: 15.04B (+1.9%)
|
23.07B
est: 22.61B (+2.0%)
|
31.99B
est: 31.57B (+1.3%)
|
42.48B
est: 43.04B (-1.3%)
|
49.17B
est: 53.70B (-8.4%)
|
51.78B
50.36B – 53.52B
-3.6% YoY
|
55.77B
50.83B – 59.02B
+7.7% YoY
|
60.55B
59.65B – 61.45B
+8.6% YoY
|
70.23B
66.06B – 73.49B
+16.0% YoY
|
74.43B
70.00B – 77.88B
+6.0% YoY
|
| EBITDA |
1.10B
est: 1.48B (-25.7%)
|
2.16B
est: 2.50B (-13.4%)
|
4.34B
est: 4.24B (+2.4%)
|
6.97B
est: 6.37B (+9.4%)
|
9.83B
est: 8.89B (+10.6%)
|
12.46B
est: 11.77B (+5.9%)
|
8.94B
est: 14.69B (-39.2%)
|
14.16B
13.77B – 14.64B
-3.6% YoY
|
15.25B
13.90B – 16.14B
+7.7% YoY
|
16.56B
16.31B – 16.81B
+8.6% YoY
|
19.21B
18.07B – 20.10B
+16.0% YoY
|
20.35B
19.15B – 21.30B
+6.0% YoY
|
| EBIT |
909.74M
est: 1.26B (-27.6%)
|
1.88B
est: 2.13B (-11.8%)
|
3.78B
est: 3.61B (+4.7%)
|
6.11B
est: 5.42B (+12.7%)
|
8.62B
est: 7.57B (+13.8%)
|
10.61B
est: 9.95B (+6.6%)
|
6.17B
est: 12.41B (-50.3%)
|
11.97B
11.64B – 12.37B
-3.6% YoY
|
12.89B
11.75B – 13.64B
+7.7% YoY
|
14.00B
13.79B – 14.20B
+8.6% YoY
|
16.24B
15.27B – 16.99B
+16.0% YoY
|
17.20B
16.18B – 18.00B
+6.0% YoY
|
| Net Income |
602.64M
est: 670.82M (-10.2%)
|
1.24B
est: 1.21B (+2.0%)
|
2.63B
est: 2.56B (+2.5%)
|
4.28B
est: 4.11B (+4.0%)
|
6.31B
est: 5.98B (+5.5%)
|
7.44B
est: 7.58B (-1.8%)
|
3.66B
est: 5.83B (-37.3%)
|
2.71B
1.52B – 3.30B
-53.6% YoY
|
2.98B
1.41B – 3.42B
+10.2% YoY
|
3.51B
1.62B – 4.20B
+17.7% YoY
|
3.14B
2.90B – 3.33B
-10.6% YoY
|
3.33B
3.07B – 3.53B
+5.9% YoY
|
| SGA |
1.24B
est: 622.31M (+99.1%)
|
1.70B
est: 1.05B (+60.8%)
|
2.26B
est: 1.79B (+26.7%)
|
3.21B
est: 2.69B (+19.4%)
|
4.20B
est: 3.75B (+12.1%)
|
5.85B
est: 6.14B (-4.7%)
|
7.75B
est: 7.66B (+1.1%)
|
7.39B
7.19B – 7.64B
-3.6% YoY
|
7.96B
7.25B – 8.42B
+7.7% YoY
|
8.64B
8.51B – 8.77B
+8.6% YoY
|
10.02B
9.43B – 10.49B
+16.0% YoY
|
10.62B
9.99B – 11.11B
+6.0% YoY
|
| EPS |
6.85
est: 6.88 (-0.4%)
|
13.83
est: 12.45 (+11.1%)
|
28.07
est: 26.25 (+6.9%)
|
44.02
est: 42.16 (+4.4%)
|
64.44
est: 61.29 (+5.1%)
|
75.86
est: 78.30 (-3.1%)
|
37.52
est: 60.30 (-37.8%)
|
23.40
15.63 – 33.79
-61.2% YoY
|
23.27
14.48 – 35.07
-0.6% YoY
|
26.40
16.61 – 43.00
+13.5% YoY
|
32.20
29.71 – 34.14
+22.0% YoY
|
34.10
31.47 – 36.16
+5.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
10.27B
OE per share TTM
104.80
Owner's Yield
30.40%
Maintenance CapEx ratio
179.49%
Maint CapEx / Avg PPE
108.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 34 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 91.3K | 0.40% |
| 2 | Avantis International Small Cap Value ETF AVDV | 0.01% | 1.73M | 0.36% |
| 3 | Dimensional - International Small Cap Value ETF DISV | 0.01% | 281.2K | 0.42% |
| 4 | Dimensional - International Small Cap ETF DFIS | 0.01% | 313.0K | 0.39% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 372.2K | 0.06% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 6.8K | 0.30% |
| 7 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 15.4K | 0.45% |
| 8 | Avantis Responsible International Equity ETF AVSD | 0.00% | 9.8K | 0.23% |
| 9 | iShares Core TOPIX ETF 1475.T | 0.00% | 256.9K | 0.05% |
| 10 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 153.8K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.52M
Shares Outstanding
98.10M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Keiichi Shibahara | Chairman, CEO & Representative Director | — | male |
| Noriaki Matsubara | Executive Officer & CFO | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7071.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
